Advice issued on soya-based formulas (January 2004)
1*
The CMO is reiterating advice that soya-based infant formulas should not be used as the first choice for management of infants with proven cows’ milk protein sensitivity, lactose intolerance, galactokinese deficiency and galactosaemia.
Soya-based formulas have a high phytoestrogen content, which could pose a risk to the long-term reproductive health of infants, according to a 2003 report from the Committee of Toxicity (COT), an independent scientific committee that advises the Department of Health and other government agencies.
BREASTFEEDING IS BEST FOR BABIES
*Department of Health. Chief Medical Officer’s Update 37, 2004
recommended for cows’ milk protein allergy under 6 months
Experts agree soya formulas should not be used in infants under 6 months for CMPA or as a first-line treatment over 6 months1-3
of infants fed soya formulas develop symptoms of soya protein allergy2
.
. Furthermore, research has shown that 30-50% .
This could explain why infants with CMPA currently average and is tolerated by 97% of infants6 .
Soya formulas are NOT 1-3
18.2 GP visits over 12 months and 42% are referred to a hospital clinician4
A more effective and time saving solution for parents and infants is Aptamil Pepti – the extensively hydrolysed whey protein formula that is proven to alleviate the symptoms of CMPA5
For further information please visit our HCP website
aptamilprofessional.co.uk or call our helpline 0800 996 1234
The Aptamil Pepti range is available to order under medical supervision as follows: Milupa Aptamil Pepti 1 (allergy) 400g: 346-5689, Milupa Aptamil Pepti 1 (allergy) 900g: 346-5671, Milupa Aptamil Pepti 2 (allergy) 900g: 359-7002
IMPORTANT NOTICE: Aptamil Pepti 1 & 2 should only be used under medical supervision, after full consideration of the feeding options available including breastfeeding. Aptamil Pepti 1 is suitable for use as the sole source of nutrition for infants from birth to 6 months of age. Aptamil Pepti 2 is suitable for babies over 6 months as part of a mixed diet, and as a principle source of nourishment with other foods. References: 1. Department of Health. CMO’s Update 37-January 2004. London: Department of Health, 2004: Available at:
http://www.dh.gov.uk/en/ Publicationsandstatistics/Lettersandcirculars/CMOupdate/DH_4070172 [Accessed September 2011]. 2. ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2006;42:352-61. 3. BDA Paediatric Group. Paediatric Group Position Statement: use of infant formulas based on soy protein for infants. Birmingham: BDA, 2010. Available at:
http://www.bda.uk.com/publications/PaediatricGroupGuidelineSoyInfantFormulas.pdf [Accessed October 2011]. 4. Sladkevicius E et al. J Med Econ 2010;13(1):119-28. 5. Verwimp JJ et al. Eur J Clin Nutr. 1995;49(Suppl 1):S39. 6. Giampietro PG et al. Pediatr Allergy Immunol. 2001;12:83-6.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47